Immediate Loading of 4 Guided Implants Supporting a Maxillary Overdenture Using a Novaloc TiN Retention System

NCT ID: NCT06083506

Last Updated: 2025-07-20

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

17 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-03

Study Completion Date

2023-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Complete dentures represent the traditional dental treatment for patients without teeth. However, retention and stability of this type of denture are often lacking, so dental implants are indicated in order to improve the stability of the denture, along with the satisfaction of the patient. Usually, the dental implants are inserted and then a period of 3-6 months is waited before any denture is connected to them. Recent studies have demonstrated that connecting the lower denture to the implants immediately after the implant placement, leads to an improvement in the result, with a social and psychological benefit for the patient. Therefore, the aim of this research project is to evaluate the application of the immediate connections of the implants for the upper dentures. 15-40 patients wearing an upper denture will receive 4 dental implants and the denture will be immediately connected. To simplify the surgical procedure, the implants will be placed without exposing the bone. This surgical technique is called guided surgery. Secondary objective of this research project will be the evaluation of the precision of the implant positioning, using this specific technique. The patients will be followed up for 12 months, for the implant and denture evaluation, as well as the evaluation of patient satisfaction and impact on quality of life through questionnaires.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Immediate Dental Implant Loading Denture, Complete

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NOVALOC TiN

Each subject will receive 4 implants. Implants will be placed flapless using a guided surgical protocol and will be immediately loaded by means of a NOVALOC TiN retained maxillary overdenture.

Group Type OTHER

NOVALOC TiN retained maxillary overdenture

Intervention Type DEVICE

4 implants immediately loaded by means of a NOVALOC TiN retained maxillary overdenture

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NOVALOC TiN retained maxillary overdenture

4 implants immediately loaded by means of a NOVALOC TiN retained maxillary overdenture

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Fully edentulous maxilla
* The implant site has to be healed for at least 4 months after extraction
* Wearing complete dentures deemed adequate
* Orthopantomogram available (OPT)
* Adequate amount of bone at least at the 2nd premolar position to house a 3.75 x 10 mm implant
* No bone grafting required
* Implant IT ≥ 20 N/cm

Exclusion Criteria

* Conditions requiring chronic routine prophylactic use of antibiotics
* Conditions requiring prolonged use of steroids
* History of leukocyte dysfunction and deficiencies
* Bleeding disorders
* History of neoplastic disease requiring use of radiation or chemotherapy
* Metabolic bone disorders
* Uncontrolled endocrine disorder
* Use of any investigational drug or device within the 30-day period prior to implant surgery
* Smoking more than 10 cigarettes a day
* Alcoholism or drug abuse
* Patient infected with HIV
* Condition or circumstances, in the opinion of the investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance, unreliability.


* Local inflammation including untreated periodontitis
* Mucosal disease such as erosive lichen planus
* History of local irradiation therapy
* Osseous lesion
* Severe bruxism and clenching habits
* Active infection with suppuration or fistula track
* Persistent intraoral infection
* Lack of primary stability \<20Ncm. In this instance, the patient must be withdrawn and treated according to the standard protocol.
* Inadequate oral hygiene or unmotivated home care.
* Bone grafting
* Inadequate bone volume for implants insertion as measured on the per-treatment CBCT.
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Straumann AG

INDUSTRY

Sponsor Role collaborator

West Virginia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arif Salman, BDS, MDSc

Role: PRINCIPAL_INVESTIGATOR

West Virginia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

West Virginia University

Morgantown, West Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1801929813

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.